SCHEMBL4653873

SCHEMBL4653873

COc1cccc(OC)c1-c1ccc2cc(C(C)=C(NC(C)=O)C(=O)O)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.41
RARB P10826 3/20 0.41
RARG P13631 3/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 1/20 0.39
ABL1 P00519 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
FABP3 P05413 1/20 0.37
FABP4 P15090 1/20 0.37
FABP5 Q01469 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6142291 0.78 CES2 (0.49) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL10464263 0.77 CA12 (0.56) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL3317813 0.76 ALDH1A1 (0.44) SIRT2HSD17B1HSD17B2ABL1ALDH1A1
SCHEMBL3317810 0.76 ALDH1A1 (0.44) SIRT2HSD17B1HSD17B2ABL1ALDH1A1
SCHEMBL8654881 0.72 CA1 (0.52) ALDH1A1MAPTCYP19A1
SCHEMBL14339176 0.70 HSD17B1 (0.37) SIRT2HSD17B1HSD17B2ABL1ALDH1A1
SCHEMBL4626690 0.68 ITGB1 (0.55)
SCHEMBL3315261 0.68 ESR1 (0.63) HSD17B1HSD17B2ABL1MEN1KMT2A
SCHEMBL10465657 0.68 ALDH1A1 (0.52) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL2040154 0.68 CA1 (0.55) MEN1KMT2APOLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP claimed